R1 RCM Inc. Nasdaq

Equities

RCM

US7493971052

Healthcare Facilities & Services

Delayed Nasdaq 03:48:59 2024-04-16 pm EDT 5-day change 1st Jan Change
12.25 USD -0.65% Intraday chart for R1 RCM Inc. -3.45% -48.12%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Stock Futures -2- DJ
KeyBanc Downgrades R1 RCM to Sector Weight From Overweight on Potential Risks to Hospital End Markets MT
North American Morning Briefing : Traders Await -2- DJ
North American Morning Briefing : Investors -2- DJ
News Highlights : Top Financial Services News of the Day - Thursday at 12 AM ET DJ
News Highlights : Top Financial Services News of the Day - Wednesday at 4 PM ET DJ
Canaccord Genuity Trims Price Target on R1 RCM to $16 From $17, Maintains Buy Rating MT
Citigroup Upgrades R1 RCM to Buy From Neutral, Price Target is $16 MT
R1 RCM Calls for Halt to Talks About Potential Deal MT
Transcript : R1 RCM Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 04:35 PM
R1 RCM Forms Special Committee to Evaluate Strategic Alternatives MT
North American Morning Briefing : Stock Futures -2- DJ
Truist Securities Downgrades R1 RCM to Hold From Buy, Price Target is $16 MT
Transcript : R1 RCM Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 10:30 AM
KeyBanc Raises Price Target on R1 RCM to $17 From $13, Maintains Overweight Rating MT
North American Morning Briefing : Fed's Preferred -2- DJ
Barclays Downgrades R1 RCM to Equalweight From Overweight, Price Target is $14 MT
Evercore ISI Downgrades R1 RCM to In Line From Outperform, Raises Price Target to $16 From $12 MT
Deutsche Bank Downgrades R1 RCM to Hold From Buy, $15 Price Target MT
Sector Update: Health Care Stocks Mixed Premarket Tuesday MT
R1 RCM Reports Breakeven Q4 Earnings; Revenue Rises; 2024 Outlook Issued, Shares Advance Pre-Bell MT
Transcript : R1 RCM Inc., Q4 2023 Earnings Call, Feb 27, 2024
R1 RCM Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
R1 RCM Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
R1 RCM Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chart R1 RCM Inc.
More charts
R1 RCM Inc. is a provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups. The Company’s scalable operating models seamlessly complement a healthcare organization’s infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The Company delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. It serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
12.33 USD
Average target price
16.93 USD
Spread / Average Target
+37.30%
Consensus
  1. Stock Market
  2. Equities
  3. RCM Stock
  4. RCM Stock
  5. News R1 RCM Inc.
  6. R1 RCM : Signs Preferred Stock Conversion Deal With Ascension Health, TowerBrook Capital